Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2026-01-08 @ 1:48 AM
Study NCT ID:
NCT01820260
Status:
COMPLETED
Last Update Posted:
2025-03-13
First Post:
2013-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis
Sponsor:
LEO Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-25
First Submit QC Date:
None
Study First Post Date:
2013-03-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-30
Results First Submit QC Date:
None
Results First Post Date:
2021-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-07-27
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-03-13
Last Update Post Date Type:
ACTUAL